If osteoporosis patients stop taking injectable bisphosphonate used to treat osteoporosis before dental treatment for a ...

Standard first-line drug therapies for the treatment of bone density disorders have been linked to higher risk of experiencing a cardiovascular event, according to a study published June 26 in Epic ...

Osteoporosis is a disease that makes bones weak and more likely to break. Sometimes, a person may break a bone from a small ...

These findings echo those of other studies that find up to 58% of patients who have an indication do not initiate antiresorptive medication after post-fracture OP screening, [8] 74% stop taking ...

Despite the risk of subsequent fractures in patients with osteoporosis, only approximately 20% of patients nationally receive ...

Samsung Bioepis announced on the 1st that it will launch the osteoporosis treatment for menopausal women, Obodence ...

The #1 Early Sign of Osteoporosis Most People Miss, According to Orthopedists first appeared on Parade on Jul 3, 2025 This ...

Around 14,000 women in England may soon be able to access a new treatment for osteoporosis after NICE backed routine NHS use of Theramex's Eladynos. The health technology assessment (HTA) agency ...

In the phase III FRAME study of postmenopausal women with osteoporosis, there was a 73% relative risk reduction in new vertebral fractures among those receiving romosozumab for 12 months compared ...

Today's conversation focuses on osteoporosis. St. Joseph's Candler endocrinologist Dr. Carolyn Nelson explains what is it and ...

Treatment for osteoporosis often follows diagnosis after a fracture event, but may be initiated earlier if risk factors for a diseased patient are identified.

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced ...